Search

Your search keyword '"Kinkhabwala M"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Kinkhabwala M" Remove constraint Author: "Kinkhabwala M" Search Limiters Full Text Remove constraint Search Limiters: Full Text
80 results on '"Kinkhabwala M"'

Search Results

1. Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma in a Diverse and Underserved Population in the United States

2. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

3. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

4. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

6. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study

7. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

19. Analysis of Donor Risk in Living-Donor Hepatectomy: The Impact of Resection Type on Clinical Outcome

20. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

21. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

22. A Rare Case of Anemia Secondary to Lice Infestation.

24. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.

25. Comparison of 1-Year Morbidity Following Liver Transplant for Acute Alcoholic Hepatitis Versus Alcoholic Cirrhosis.

26. A Safe Anti-A2 Titer for a Successful A2 Incompatible Kidney Transplantation: A Single-center Experience and Review of the Literature.

28. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.

29. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.

30. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma.

31. Centers with more therapeutic modalities are associated with improved outcomes for patients with hepatocellular carcinoma.

33. Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients.

34. Arterial Inflammation Detected With 18 F-Fluorodeoxyglucose-Positron Emission Tomography in Rheumatoid Arthritis.

35. Bridging therapy effectiveness in the treatment of hepatocellular carcinoma prior to orthotopic liver transplantation.

36. Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study.

37. Cardiac failure after liver transplantation requiring a biventricular assist device.

38. Expedited liver allocation in the United States: a critical analysis.

39. Campath induction in HCV and HCV/HIV-seropositive kidney transplant recipients.

40. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C.

42. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation.

43. Predictors of candidate maturation among potential living donors.

44. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation.

45. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.

46. One-year morbidity after donor right hepatectomy.

47. Microvascular hepatic artery anastomosis in pediatric segmental liver transplantation: microscope vs loupe.

48. Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation.

49. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors.

50. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.

Catalog

Books, media, physical & digital resources